"Sarcoma, Ewing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Descriptor ID |
D012512
|
| MeSH Number(s) |
C04.557.450.565.575.650.800 C04.557.450.795.620.800
|
| Concept/Terms |
Sarcoma, Ewing- Sarcoma, Ewing
- Sarcoma, Ewing's
- Sarcoma, Ewings
- Ewing's Sarcoma
- Ewings Sarcoma
- Ewing's Tumor
- Ewings Tumor
- Tumor, Ewing's
- Ewing Sarcoma
- Ewing Tumor
- Tumor, Ewing
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma, Ewing".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma, Ewing".
This graph shows the total number of publications written about "Sarcoma, Ewing" by people in this website by year, and whether "Sarcoma, Ewing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 2 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 2 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 4 | 0 | 4 |
| 2022 | 4 | 0 | 4 |
| 2023 | 5 | 0 | 5 |
| 2024 | 4 | 1 | 5 |
| 2025 | 4 | 0 | 4 |
| 2026 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma, Ewing" by people in Profiles.
-
Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10-Year, Single-Institution Experience Encompassing the COVID-19 Pandemic. Pediatr Blood Cancer. 2026 Aug; 73(8):e70390.
-
A Unique Case of Gross Hematuria in a Patient With Ewing Sarcoma. J Pediatr Hematol Oncol. 2025 04 01; 47(3):140-143.
-
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board. Cancer. 2024 Dec 01; 130(23):4028-4039.
-
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma. Pediatr Hematol Oncol. 2023 May; 40(4):422-428.
-
p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. Oncogene. 2021 02; 40(6):1176-1190.
-
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep. 2019 11 05; 29(6):1675-1689.e9.
-
In?Vitro and In?Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):118-127.
-
miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma. Int J Cancer. 2017 11 15; 141(10):2062-2075.
-
Initial diagnostic management of pediatric bone tumors. J Pediatr Surg. 2016 Jun; 51(6):981-5.
-
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015 May 20; 33(15):1688-96.